Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach-Reference-Cited by-同舟云学术

Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach

Published:2023-11 Issue: Volume:260 Page:115713
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bhattacharya Debomita,Shi Ming Li Alice,Paul Barnali,Ghosh Dastidar Uddipta,Santhakumar Vijayaratnam,Sarkar Dipika,Chau Irene,Li Fengling,Ghosh Trisha,Vedadi Masoud,Talukdar Arindam^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference51 articles.

1. Epigenetic mechanisms in DNA double strand break repair: a clinical review;Fernandez;Front. Mol. Biosci.,2021

2. Epigenetics in alternative pre-mRNA splicing;Luco;Cell,2011

3. Protein arginine methylation/demethylation and cancer;Poulard;Oncotarget,2016

4. Arginine methylation: the coming of age;Blanc;Mol. Cell,2017

5. DNA methylation, early life environment, and health outcomes;Mitchell;Pediatr. Res.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the PRMT6 modulators in cancer treatment: Current progress and emerged opportunity;European Journal of Medicinal Chemistry;2024-12

2. Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation;Journal of Medicinal Chemistry;2024-05-08

3. Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy;European Journal of Medicinal Chemistry;2024-04

4. Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH;Life Sciences;2024-04

5. Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis;Journal of Medicinal Chemistry;2023-12-15